{
    "2021-11-18": [
        [
            {
                "time": "2022-11-01",
                "original_text": "近期多家药企公布新冠药物进展，部分上市公司或趁机“蹭热点”。",
                "features": {
                    "keywords": [
                        "新冠药物",
                        "药企",
                        "蹭热点"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2022-11-01",
                "original_text": "又有千亿医药巨头放大招！赴港二次上市。",
                "features": {
                    "keywords": [
                        "医药巨头",
                        "赴港",
                        "二次上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-11-01",
                "original_text": "华兰股份：公司和凯莱英有合作关系。",
                "features": {
                    "keywords": [
                        "华兰股份",
                        "凯莱英",
                        "合作关系"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-11-01",
                "original_text": "21股今日获机构买入评级。",
                "features": {
                    "keywords": [
                        "机构买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-11-01",
                "original_text": "天风证券：维持凯莱英(002821.SZ)“买入”评级 签署重大合同 产能稳定释放。",
                "features": {
                    "keywords": [
                        "天风证券",
                        "凯莱英",
                        "买入评级",
                        "重大合同",
                        "产能释放"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-11-01",
                "original_text": "华泰证券：维持凯莱英(002821.SZ)“买入”评级 目标价533.93元。",
                "features": {
                    "keywords": [
                        "华泰证券",
                        "凯莱英",
                        "买入评级",
                        "目标价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-11-01",
                "original_text": "凯莱英通过港交所聆讯，多家大型银行持股。",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "港交所聆讯",
                        "大型银行持股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-11-01",
                "original_text": "医药生物行业深度报告：创新药行业景气 医药新零售东风已起。",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新药",
                        "行业景气",
                        "医药新零售"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-11-01",
                "original_text": "港股IPO|凯莱英通过港交所聆讯 A股上市五年后再赴港股。",
                "features": {
                    "keywords": [
                        "港股IPO",
                        "凯莱英",
                        "港交所聆讯",
                        "A股上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-11-01",
                "original_text": "新冠特效药热度蔓延至A股：拓新药业暴涨185%后被问询停牌、翰宇药业股价翻倍后又暴跌，拼业绩还是炒概念？",
                "features": {
                    "keywords": [
                        "新冠特效药",
                        "拓新药业",
                        "翰宇药业",
                        "暴涨",
                        "暴跌",
                        "炒概念"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}